Dr. Gregory S. Long

John C. Rhee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Rhee is skilled in the management of all forms of cancer and blood diseases, with particular interest in cancers of the gastrointestinal tract and chest, including colorectal, esophageal, gastric, pancreaticobiliary, liver, neuroendocrine, and lung tumors. Dr. Rhee is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Colorectal Cancer, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Gamma Knife Radiosurgery, and Gastrostomy.

Nour Daboul is a Hematologist Oncology specialist and a Hematologist in Morgantown, West Virginia. Dr. Daboul is rated as an Advanced provider by MediFind in the treatment of Gallbladder Cancer. Her top areas of expertise are Familial Colorectal Cancer, Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer. Dr. Daboul is currently accepting new patients.

Melissa K. Yee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center.  She specializes in the treatment of solid tumors and blood disorders. Dr. Yee is board-certified by the American Board of Internal Medicine in medical oncology, hematology, and internal medicine.  She received her medical degree from the Drexel University College of Medicine in Philadelphia. She then completed her internal medicine residency and hematology/oncology fellowship at UPMC. She earned her undergraduate degree from Tufts University. After completion of her medical training, she was on staff at Dana Farber Cancer Institute in Boston before returning to Pittsburgh to practice at UPMC Mercy. Dr. Yee is a member of the American Society of Clinical Oncology, American Association for Cancer Research, and American Society of Hematology, and Massachusetts Medical Society. Dr. Yee is rated as an Advanced provider by MediFind in the treatment of Gallbladder Cancer. Her top areas of expertise are Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Pleuropulmonary Blastoma.